article thumbnail

Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes

Xconomy

Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). —When Merck (NYSE: MRK ) bought Cubist Pharmaceuticals for $9.5

article thumbnail

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. So far at the company I have raised seed funds of $500,000 of which $470,000 is still in the bank so I’m in pretty good shape. My blog was wiped out. Page 3: Competition.

article thumbnail

Frank Addantes FounderBlog: Startup 5.0 – I’m just going to chill out for a bit… (OK, for a month…)

Frank Addante

He went from recruiter to IT manager to technical sales… Then, he did such a great job in sales that we had to build up more infrastructure for our ad-serving and email delivery platform to support the increased demand. So, I put him in charge of our data centers and technical operations.

Startup 40